Clinical Trials · NCT01184859
Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 116
- Start date
- Jul 2010
- Locations
- 36 sites, Japan
- Primary endpoint
- Duration of Action Defined as the Time With Urine Osmolality Above 200 mOsm/kg - Period 1